Textiles: spinning – twisting – and twining
Patent
1998-04-24
2000-02-15
Carlson, Karen Cochrane
Textiles: spinning, twisting, and twining
424 9464, 530350, 530380, A61K 3817, A61K 3846, C07K 14435
Patent
active
06024688&
ABSTRACT:
Fragments of an endothelial cell proliferation inhibitor and method of use therefor are provided. The endothelial proliferation inhibitor is a protein derived from plasminogen, or more specifically is an angiostatin fragment. The angiostatin fragments generally correspond to kringle structures occurring within the endothelial cell proliferation inhibitor. The endothelial cell inhibiting activity of these fragments provides a means for inhibiting angiogenesis of tumors and for treating angiogenic-mediated disease.
REFERENCES:
patent: 5639725 (1997-06-01), O'Reilly et al.
patent: 5733876 (1998-03-01), O'Reilly et al.
patent: 5837682 (1998-11-01), Folkman et al.
Abe, N. et al., "Identification of a Novel Collagen Chain Represented by Extensive Interruptions in the Triple-Helical Region", Biochem. and Biophys. Rsch. Comm., vol. 196, No. 2, pp. 576-582 (1993).
Algire, G.H. et al., "Vascular reactions of normal and malignant tumors in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants", J. Natl. Canc. Inst., vol. 6, pp. 73-85 (1945).
Angiolilllo, A.1. et al., "Human interferon-inducible Protein 10 is a potent inhibitor of angiogenesis in vivo", J. Exp. Med., vol. 182, pp. 155-162 (1995).
Brem, H. et al., "Intestinal chemotherapy with drug polymer implants for the treatment of recurrent gliomas", J. Neurosurg., vol. 74, pp. 441-446 (1991).
Brockway, W.J. et al., "Measurement of the Binding of Antifibrinolytic Amino Acids to Various Plasminogens", Arch. Biochem. Biophys., vol. 151, pp. 194-199 (1972).
Browne, M.J. et al., "Expression of Recombinant Human Plasminogen and Aglycoplasminogen in HeLa Cells", Fibrinolysis, vol. 5, pp. 257-260 (1991).
Cao, Y. et al., "gro-.beta., .alpha.-C-X-C-Chemokine, Is an Angiogenesis Inhibitor That Suppresses the Growth of Lewis Lung Carcinoma in Mice", J. Esp. Med., vol. 182, pp. 2069-2077 (1995).
Chen, C. et al., "A Strategy to Discover Circulating Angiogenesis Inhibitors Generated by Human Tumors", Canc. Resch., vol. 55, pp. 4230-4233 (1995).
Church, W.R. et al., "A Kringle-Specific Monoclonal Antibody", Hybridoma, vol. 13, No. 5, pp. 423-429, Oct. 1994.
Clapp, C. et al., "The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis", Endocrinology, vol. 133, pp. 1292-1299 (1993).
Cleary, S. Mulkerrin et al., "Purification and Characterization of Tissue Plasminogen Activator Kringle-.sup.2 Domain Expressed in Escherichia coli", Biochem., vol. 28, pp. 1884-1891 (1989).
Dameron, K.M. et al., "Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1", Science, vol. 265, pp. 1582-1584 (1994).
Folkman, J., "Tumor angiogenesis and tissue factor", Nature Med.vol. 2, pp. 167-168 (1996).
Folkman, J., "What is the Evidence that Tumors are Angiogenesis Dependent?", J. Natl Canc Inst., vol. 82, pp. 4-6 (1990).
Folkman, J., "Angiogenesis in cancer, vascular, rheumatoid and other disease", Nature Medicine, vol. 1, No. 1, pp. 27-31 (1995).
Folkman, J., "Long-term culture of capillary endothelial cells", Proc. Natl. Acad. Sci. USA 76, pp. 5217-5221 (1979).
Folkman, J., "Induction of angiogenesis during the transition from hyperplasia to neoplasia", Nature, vol. 339, pp. 58-61 (1989).
Folkman, J., "Tumor Behavior in Isolated Perfused Organs In Vitro Growth and Metastases of Biopsy Material in Rabbit Thyroid and Canine Intestinal Segment", Annals of Surgery, vol. 164, No. 3, pp. 491-501 (1996).
Folkman, J., "Angiogenesis and Its Inhibitors", Important Advances in Oncology, J.B. Lippincott Company, pp. 42-62 (1985).
Folkman, J., "Tumor Angiogenesis Therapeutic Implications", NE J. of Med., No. 18, pp. 1182-1186 (1971).
Gavrieli, Y. et al., "Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation", J.CellBiol., vol. 119, pp. 493-501 (1992).
Gimbrone, M.A. et al., "Tumor Growth and Neovascularization An Experimental Model using the Rabbit Cornea", J. Natl. Canc. Inst., vol. 52, No. 2, pp. 413-427 (1974).
Gimbrone, M.A. et al., "Tumor Dormancy in Vivo by Prevention of Neovasculariztaion", J. of Experi. Med., vol. 136, pp. 261-276 (1972).
Good, D.J. et al., "A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin", Proc. Nat. Acad. Sci. USA, vol. 87, pp. 6624-6628 (1990).
Grant, D.S. et al., "Scatter factor induces blood vessel formation in vivo", Proc. Natl. Acad. Sci. USA, vol. 99, pp. 1937-1941 (1993).
Grant, D.S. et al., "Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro", Cell, vol. 58, pp. 933-943 (1989).
Gross, J.L. et al., "Modulation of Solid Tumor Growth in vivo by bFGF", Proc. Amer. Assoc. Canc. Resh, vol. 31, p. 79 (1990).
Gross, J.L. et al., "Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro", Proc. Natl. Acad. Sci. USA, vol. 80, pp. 2623-2627 (1983).
Gunzler, W.A. et al., "The Primary Structure of High Molecular Mass Urokinase from Human Urine", Hoppe-Seyler's Z. Physiol. Chem., vol. 363, pp. 1155-1165 (1982).
Gupta, S.K. et al., "A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4", Proc. Natl. Acad. Sci. USA, vol. 92, pp. 7779-7803 (1995).
Holmgren, L. et al., "Dormancy of micrometastases. Balanced proliferation and apoptosis in the presence of angiogenesis suppression", Nature Medicine, vol. 1, No. 2, pp. 149-153 (1995).
Homandberg, G.A. et al., "Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth", Am. J. Path., vol. 120, pp. 327-332 (1985).
Hori, A. et al., "Suppression of Solid tumor Growth by Immunoneutralizing Monoclonal Antibody against Human Basic Fibroblast Growth Factor", Canc. Resch., vol. 51, pp,. 6180-6184 (1991).
Ingber, D. et al., "Synthetic Protein B: Disulfide Bridges, Structural Properties, and Kringle Similarities", Biochem., vol. 30, pp. 6917-6921 (1991).
Johansson, J. et al., "Surfactant Protein B: Disulfide Bridges, Structural Properties, and Kringle Similarities", Biochem., vol. 30, pp. 6917-6921 (1991).
Kandel, J. et al., "Neovascularization is Associated with a Switch to the Export of bFGF in the Multistep Development of Fibrosarcoma", Cell, vol. 66, pp. 1095-1104 (1991).
Kim, K.J. et al., "Inhibition of vascular endothelial growth factor-induced angiogenesis supresses tumor growth in vivo", Nature, vol. 362, pp. 841-844 (1993).
Kivirikko, S. et al., "Primary Structure of the .alpha.1 Chain of Human Type XV Collagen and Exon-Intron Organization in the 3' Region of the Corresponding Gene", J. Bio. Chem., vol. 269, No. 7, pp. 4773-4779 (1994).
Knighton, D. et al., "Avascular and Vascular Phases of Tumor Growth in the Chick Embryo", Br. J. Cancer, vol. 35, pp. 347-356 (1977).
Lein, W. M. et al., "The blood supply of experimental liver metastases. II. A Microciruclatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber", Surgery, vol. 68, No. 2, pp. 334-340 (1970).
Lerch et al., "Localization of Individual Lysine-Binding Regions in Human Plasminogen and Investigations on Their Complex-Forming Properties", European Journal of Biochemistry, vol. 107, No. 1, pp. 7-13 (1980).
Lokker, N.A. et al., "Mutational analysis and molecular modeling of the N-terminal kringle-containing domain of hepatocyte growth gactor identifies amino acid side chains important for interaction with the c-met receptor", Prot. Engin., vol. 7, pp. 895-903 (1994).
Maione, T.E. et al., "Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides", Science , vol. 247, pp. 77-79 (1990).
Marti, D. et al., "Expression, purification and characterization of the recombinant kringle2 and kringle 3 domains of human plasminogen and analysis of their binding affinity for .omega.-aminocarboxylic acids", Eur. J. Biochem., vol. 219, pp. 455-462 (1994).
McCance, S.G. et al., "Amino Acid Residues of the Kringle-4 and Kringle-5 Domains of Human Plasminogen That Stablize T
Cao Yihai
Folkman M. Judah
O'Reilly Michael S.
Carlson Karen Cochrane
The Children's Medical Center Corporation
LandOfFree
Angiostatin fragments and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiostatin fragments and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiostatin fragments and method of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1901739